Barouch, NEJM, Aug 31, 2022, BA5 a rapidly dwindling threat based on > 11M sequenced samples through June 19, 2022. Bi...
Aug 31st 2022 9:33pm EDT
Barouch, NEJM, Aug 31, 2022, BA5 a rapidly dwindling threat based on > 11M sequenced samples through June 19, 2022. Bivalents not medically necessary nor clinically indicated at this point. No RCT demonstrating safety and efficacy. Not a viable consideration for clinical use. https://twitter.com/p_mcculloughmd/status/1565149149410070528?s=21&t=deD5_ZhQY88wZFKR32w1mw @PeterMcCulloughMDwww.PeterMcCulloughMD.com Powered by WPeMatico
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.